Clinical Trials
3 trialsNCT05615142 2026-05-11
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
Sichuan University
Phase 1 Active not recruiting
NCT05222087 2024-08-15
PRIME_LUNG
Peter MacCallum Cancer Centre, Australia
Phase 1 Recruiting
NCT06362980 2024-07-10
EGFR
National Cancer Center, China
Phase 1 Recruiting